VX-445/TEZ/IVA

· Vertex Pharmaceuticals Incorporated

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for VX-445/TEZ/IVA, covering 2021-10-22 to 2021-10-22. Get the full timeline:

Most recent: Clinical Trial Update: Evaluation of VX 445/TEZ/IVA in Cystic Fibrosis Subjects 6 Through 11 Years of Age [Phase 3]